Comparable Sales Strength Across Enterprise
Macy's, Inc. delivered 3.0% comparable sales growth (3.1% go-forward), the company's strongest first quarter since 2022; all nameplates and channels were positive (Macy's +1.6%, Bloomingdale's +10.2%, Bluemercury +6.4%).
Net Sales and Total Revenue Growth
Net sales rose 1.8% to $4.7 billion (or +2.7% excluding ~$40M impact from non-go-forward store closures); total revenue increased 2.1% to $4.9 billion versus prior year.
Bloomingdale's Record Quarter
Bloomingdale's achieved a 10.2% comp and its highest first-quarter sales in the retailer's 154-year history, with broad-based channel and category strength.
Reimagine Program Momentum
Reimagine locations expanded to 200 stores (about 60% of go-forward Macy's stores, ~75% of 2025 Macy's store sales) and produced positive comps in 8 of the last 9 quarters; Reimagine comps grew 2.4% in Q1.
Adjusted EPS and EBITDA Above Guidance
Adjusted diluted EPS was $0.13, above the high end of prior guidance; adjusted EBITDA was $290 million (5.9% of total revenue), exceeding guidance range of 4.9%–5.1%.
Improved Cash Flow and Stronger Balance Sheet
Operating cash flow was an inflow of $292 million (vs. outflow of $64 million prior year) and free cash flow was +$140 million (vs. -$203 million prior year). Cash on hand ended at $1.3 billion (vs. $932 million prior year).
Other Revenue and Credit Performance
Other revenue grew to $210 million (+8% YoY); credit card revenue rose 12% to $172 million, reflecting a healthy credit portfolio and reduced net credit losses.
Strategic Product, Brand and Digital Initiatives
Introduced new brands and expanded brand distribution (e.g., Rotie's, Donna Karan Weekend, Ted Baker Men's); launched Ask Macy's AI conversational shopping assistant (early positive response); China distribution facility automation ramping.
Returned Capital to Shareholders and Buyback Capacity
Returned $100 million in Q1 ($50M dividend, $50M repurchases) and have approximately $1.1 billion remaining under buyback authorization.
Raised Full-Year Guidance
Company raised full-year outlook: net sales now expected $21.5B–$21.75B, comparable sales +0.5% to +1.2%, adjusted diluted EPS $2.00–$2.20 and adjusted EBITDA 7.7%–7.9% of total revenue.